Shangting Han

3PUBLICATIONS
4CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 17, 2024
ANKRD1 aggravates renal ischaemia‒reperfusion injury via promoting TRIM25-mediated ubiquitination of ACSL3.

Shangting Han, Jiayu Guo, Chenyang Kong

|Nov 26, 2022
Ferroptosis-A New Dawn in the Treatment of Organ Ischemia-Reperfusion Injury.

Linxiang Zhou, Shangting Han, Jiayu Guo

Pageof 1